Targeted therapies for the treatment of GI-ARS diarrhea
Ended Project Grant Awarded Last action
- Award ID
- R41DK125208
- Recipient
-
Rxbio, Inc. UEI DB9LSMAHKNJ8
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $252,128
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Memphis, TN 38163, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $252,128 |
Quick answers
Who received award R41DK125208?
R41DK125208 was awarded to Rxbio, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 18, 2020.
How much is award R41DK125208 worth?
$252,128 has been obligated on R41DK125208.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award